2BBBullish & Bearish
Health Care

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Stock Score & Signals

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 26 out of 100.

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines.

2BB score and signals

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)’s current 2BB score is 26 out of 100, built from the signal categories below.

SignalScoreReading
Activity12Very Low
Momentum48Stable
Financial strength19Very Weak
Quality100Very Strong
Risk0Very Low

Company facts

CEOChristophe Weber | Christophe Weber
FoundedJun 12, 1781
Employees47K
52-week range$12.99 – $18.90

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2026-10-2847.571$1158.05B
2026-07-3053.0587$1165.47B
2026-05-13-23.9925$1131.87B